LAURIE MILLER: Open Payments
NPI 1063693893 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,324 in 70 payments from 15 companies in 2025. Trend: 2023 $523 · 2024 $439 · 2025 $1,324
Food & beverage: $1,324
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 17 | $318 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $234 |
| Axsome Therapeutics, Inc. | 10 | $192 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $152 |
| ABBVIE INC. | 5 | $101 |
| Lundbeck LLC | 4 | $81 |
| Janssen Pharmaceuticals, Inc | 3 | $65 |
| Collegium Pharmaceutical, Inc. | 2 | $42 |
| Alkermes, Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
Products named: REXULTI, CAPLYTA, Auvelity, TRINTELLIX, VRAYLAR, Jornay PM, SPRAVATO, XARELTO.
Industry payments across TN — which companies pay providers there.
